Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enphase Energy Inc (ENPH) vs Heron Therapeutics Inc (HRTX) Price & Performance

Enphase Energy IncTrade
Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Enphase Energy Inc vs Heron Therapeutics Inc — how do they compare? Enphase Energy Inc trades at $42.54 (market cap $5.41B), while Heron Therapeutics Inc trades at $0.32 (market cap $63.41M). The key difference: Enphase Energy Inc is far larger — about 85.3× Heron Therapeutics Inc's market cap, and Enphase Energy Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

ENPHHRTX
Market Cap
$5.41B$63.41M
Sector
TechnologyHealth
52-Week High
$72.33$1.49
52-Week Low
$26.12$0.32
Enterprise Value
$5.05B$161.31M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enphase Energy Inc

No Aura AI signal available yet.

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.

HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Enphase Energy Inc

Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.

Read more on ENPH

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX